One pill to tackle two heart risks: new combo therapy tested

NCT ID NCT07564726

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed Phase 3 trial tested whether a single pill combining ezetimibe, rosuvastatin, and amlodipine can safely lower both cholesterol and blood pressure in 163 Korean adults with hypertension and high cholesterol. Participants took the combination pill or a control for 8 weeks. The study measured changes in LDL cholesterol and systolic blood pressure to see if the combo works better than separate treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ezetimibe/Rosuvastatin and Amlodipine combination pill
What this could lead to
If successful, this could offer a convenient once-daily pill that manages both high cholesterol and high blood pressure, potentially improving treatment adherence.
What could go wrong
This is a completed Phase 3 trial with 163 participants, so results are limited to this specific group. The combination may not work for everyone and could cause side effects like muscle pain or dizziness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, South Korea

  • Cha University Bundang Medical Center

    Seongnam, South Korea

  • Chonnam National University Hospital

    Gwangju, South Korea

  • Daegu Catholic University Medical Center

    Daegu, South Korea

  • Dankook University Hospital

    Cheonan, South Korea

  • Gachon University Gil Medical Center

    Incheon, South Korea

  • Hallym University Sacred Heart Hospital

    Anyang, South Korea

  • Jeonbuk National University Hospital

    Jeonju, South Korea

  • Kangbuk Samsung Hospital

    Seoul, South Korea

  • Keimyung University Dongsan Medical Center

    Daegu, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Korea University Ansan Hospital

    Ansan, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • Kosin University Gospel Hospital

    Busan, South Korea

  • Nowon Eulji Medical Center, Eulji University

    Seoul, South Korea

  • Pusan National University Hospital

    Busan, South Korea

  • Severance Hospital

    Seoul, South Korea

  • The Catholic University of Korea Seoul St. Mary's Hospital

    Seoul, South Korea

  • The Catholic University of Korea Uijeongbu St. Mary's Hospital

    Uijeongbu-si, South Korea

  • Uijeongbu Eulji Medical Center, Eulji University

    Uijeongbu-si, South Korea

  • Yeungnam University Hospital

    Daegu, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.